These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 8708541)
1. Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action. Srinivasan N; Edwall D; Linkhart TA; Baylink DJ; Mohan S J Endocrinol; 1996 May; 149(2):297-303. PubMed ID: 8708541 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Kimura G; Kasuya J; Giannini S; Honda Y; Mohan S; Kawachi M; Akimoto M; Fujita-Yamaguchi Y Int J Urol; 1996 Jan; 3(1):39-46. PubMed ID: 8646598 [TBL] [Abstract][Full Text] [Related]
3. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. McCarthy TL; Casinghino S; Centrella M; Canalis E J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403 [TBL] [Abstract][Full Text] [Related]
4. An inhibitory insulin-like growth factor binding protein (In-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived In-IGFBP. Perkel VS; Mohan S; Baylink DJ; Linkhart TA J Clin Endocrinol Metab; 1990 Aug; 71(2):533-5. PubMed ID: 1696279 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4. Ceda GP; Fielder PJ; Henzel WJ; Louie A; Donovan SM; Hoffman AR; Rosenfeld RG Endocrinology; 1991 Jun; 128(6):2815-24. PubMed ID: 1709857 [TBL] [Abstract][Full Text] [Related]
6. Interaction of insulin-like growth factor II (IGF-II) with multiple plasma proteins: high affinity binding of plasminogen to IGF-II and IGF-binding protein-3. Oesterreicher S; Blum WF; Schmidt B; Braulke T; Kübler B J Biol Chem; 2005 Mar; 280(11):9994-10000. PubMed ID: 15642732 [TBL] [Abstract][Full Text] [Related]
7. IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. Kaicer E; Blat C; Imbenotte J; Troalen F; Cussenot O; Calvo F; Harel L Growth Regul; 1993 Sep; 3(3):180-9. PubMed ID: 7693099 [TBL] [Abstract][Full Text] [Related]
8. Production of the rat type 1 insulin-like growth factor-binding protein by well differentiated H4EIIC3 hepatoma cells: identification, purification, and N-terminal amino acid analysis. Unterman TG; Oehler DT; Gotway MB; Morris PW Endocrinology; 1990 Aug; 127(2):789-97. PubMed ID: 2164920 [TBL] [Abstract][Full Text] [Related]
9. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding. Headey SJ; Leeding KS; Norton RS; Bach LA J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596 [TBL] [Abstract][Full Text] [Related]
10. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. Bach LA; Hsieh S; Sakano K; Fujiwara H; Perdue JF; Rechler MM J Biol Chem; 1993 May; 268(13):9246-54. PubMed ID: 7683646 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979 [TBL] [Abstract][Full Text] [Related]
13. Surface-bound plasmin induces selective proteolysis of insulin-like-growth-factor (IGF)-binding protein-4 (IGFBP-4) and promotes autocrine IGF-II bio-availability in human colon-carcinoma cells. Remacle-Bonnet MM; Garrouste FL; Pommier GJ Int J Cancer; 1997 Sep; 72(5):835-43. PubMed ID: 9311602 [TBL] [Abstract][Full Text] [Related]
14. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes. Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845 [TBL] [Abstract][Full Text] [Related]
15. Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization. Kiefer MC; Schmid C; Waldvogel M; Schläpfer I; Futo E; Masiarz FR; Green K; Barr PJ; Zapf J Growth Regul; 1993 Mar; 3(1):56-9. PubMed ID: 7683532 [TBL] [Abstract][Full Text] [Related]
16. Expression, purification and characterization of the structure and disulfide linkages of insulin-like growth factor binding protein-4. Chelius D; Baldwin MA; Lu X; Spencer EM J Endocrinol; 2001 Feb; 168(2):283-96. PubMed ID: 11182766 [TBL] [Abstract][Full Text] [Related]
17. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6. Bond JJ; Meka S; Baxter RC J Endocrinol; 2000 May; 165(2):253-60. PubMed ID: 10810289 [TBL] [Abstract][Full Text] [Related]
18. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially. Lee CY; Rechler MM Endocrinology; 1995 Feb; 136(2):668-78. PubMed ID: 7530649 [TBL] [Abstract][Full Text] [Related]